4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-065221
SVP & Chief Commercial Officer sold 6,061 shares at $13.16 ($79,763)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NORTHCOTT JOHN SVP & Chief Commercial Officer | 2021-11-16 | Sale | −6,061 | $13.16 | $79,763 | 194,854 | D: show line 1 in the form |
| Open-market sales · 6,061 sh · avg $13.16 · $79,763 | |||||||
Loading xslF345X03/doc4.xml…